about
Current approaches in treatment of triple-negative breast cancerMethylsulfonylmethane suppresses breast cancer growth by down-regulating STAT3 and STAT5b pathwaysTriple-negative breast cancer: is there a treatment on the horizon?Therapeutic targets of triple-negative breast cancer: a reviewAnti-Invasive and Anti-Proliferative Synergism between Docetaxel and a Polynuclear Pd-Spermine AgentClinicopathological features and prognosis of triple negative breast cancer in Kuwait: A comparative/perspective analysis.Metabolic Portraits of Breast Cancer by HR MAS MR Spectroscopy of Intact Tissue Samples.Distinct distribution and prognostic significance of molecular subtypes of breast cancer in Chinese women: a population-based cohort study.Hormone receptor and ERBB2 status in gene expression profiles of human breast tumor samplesThe latest progress in research on triple negative breast cancer (TNBC): risk factors, possible therapeutic targets and prognostic markersTreating breast cancer in the 21st century: emerging biological therapiesCapecitabine maintenance therapy for XT chemotherapy-sensitive patients with metastatic triple-negative breast cancerHigh prevalence of human cytomegalovirus proteins and nucleic acids in primary breast cancer and metastatic sentinel lymph nodes.Feline mammary basal-like adenocarcinomas: a potential model for human triple-negative breast cancer (TNBC) with basal-like subtype.Fertility preservation and breast cancer: a reviewCOP1, the negative regulator of ETV1, influences prognosis in triple-negative breast cancer.Exploring molecular pathways of triple-negative breast cancerSelection of Novel Peptides Homing the 4T1 CELL Line: Exploring Alternative Targets for Triple Negative Breast Cancer.Expression of receptor protein tyrosine phosphatase ζ is a risk factor for triple negative breast cancer relapseWhich imaging modality is superior for prediction of response to neoadjuvant chemotherapy in patients with triple negative breast cancer?Breed- and age-related differences in canine mammary tumorsComparisons of Oncologic Outcomes between Triple-Negative Breast Cancer (TNBC) and Non-TNBC among Patients Treated with Breast-Conserving Therapy.Quantum dot-based immunofluorescent imaging and quantitative detection of TOP2A and prognostic value in triple-negative breast cancer.Epigenetic silencing of ARRDC3 expression in basal-like breast cancer cellsEvaluation of Breast Cancer Stem Cells and Intratumor Stemness Heterogeneity in Triple-negative Breast Cancer as Prognostic Factors.Breast cancer and fertility preservationThe Effect of Treatment Advances on the Mortality Results of Breast Cancer Screening Trials: A Microsimulation Model.A novel vaccinia virus with dual oncolytic and anti-angiogenic therapeutic effects against triple-negative breast cancer.Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer.Novel therapeutic strategies for malignant salivary gland tumors: lessons learned from breast cancer.TGF-β1-Induced Epithelial-Mesenchymal Transition Promotes Monocyte/Macrophage Properties in Breast Cancer Cells.CDCP1 is a novel marker of the most aggressive human triple-negative breast cancers.Androgen Receptor Expression in Thai Breast Cancer Patients.Efficacy of adjuvant chemotherapy with carboplatin for early triple negative breast cancer: a single center experience.TNBC vs. Non-TNBC: A Five-Year Retrospective Review of Differences in Mean Age, Family History, Smoking History and Stage at Diagnosis at an Inner City University Program.Clinical and genetic characterization of hereditary breast cancer in a Chinese population.The exploration of contrasting pathways in Triple Negative Breast Cancer (TNBC).Development and cytotoxic response of two proliferative MDA-MB-231 and non-proliferative SUM1315 three-dimensional cell culture models of triple-negative basal-like breast cancer cell lines.Combination Immunotherapy of MUC1 mRNA Nano-vaccine and CTLA-4 Blockade Effectively Inhibits Growth of Triple Negative Breast Cancer.BRCA Gene Mutations and Poly(ADP-Ribose) Polymerase Inhibitors in Triple-Negative Breast Cancer.
P2860
Q26801549-59D6805C-4007-4E8D-B5CE-6C01BB0F7327Q27306870-A4B8D1BF-CEE3-4F45-8D4B-AEE025167279Q28077243-70D8F521-3B45-464A-BCFB-315EBC306B75Q28081591-775BD1B6-8C7D-4543-9D5B-259CFD86AE82Q28553698-33E6F121-A350-4E9A-A0CF-5F75C1C4A9AEQ33751806-4F44968F-85A8-45BA-96D7-8BC7FA5BF7C3Q33844930-D07A5B67-1347-4ABD-8036-DDB8DAD0CB20Q33958866-C6CAF8EF-5FD9-4678-8C79-42CBFAA8E3C1Q34055901-3A9F1D47-C40D-4974-99A9-4D12221B3EFFQ34258373-9416761B-B57F-4E94-9721-46E2FD28020DQ34326536-B3B4BAC8-DD14-4763-9B0C-E189BC05ECB9Q34452707-1D77E7F8-14C3-40B6-B1F6-880B7444E8A2Q34602649-1537D75A-C4BE-4E0A-A2C2-56387C7701BFQ34978283-892421DE-7FD0-40C6-9E42-0D2431EE0613Q35106163-61412FE4-0235-402D-AF6D-F2B00EC9912DQ35237824-E6CB12E7-199C-4A83-9C0A-5216C6BAE0C9Q35959745-7BF2DD9D-6FA6-4C12-A2B0-274D779964B1Q36109029-3637D47D-080A-4168-8652-F3FC045C729DQ36524110-605096EA-0B49-4842-B6DA-18F8D7ECC2ACQ36640972-FF4C0B70-9C0D-4E2D-B079-C9D3297459E0Q36811022-0363216F-878B-4F54-A438-70C3C282AA05Q37124809-B510B665-4ACC-4264-91F3-84E7B40A347BQ37376754-6D3388AC-25B8-486A-B8FA-2BB91CDFECB5Q37511632-F9C982F8-587A-4FCB-9FF8-B6952B956D5FQ37513954-072FCADE-2083-4761-BF13-09F1F003A0D3Q37612074-C8308949-9923-4FE1-82A7-5B38DBCF1D64Q37708613-24ABB13F-81FB-4002-9441-082BC3C43A29Q38940868-C1441E17-83A4-4D17-B535-25C946A8C295Q38968841-FA9E905B-1708-425D-B148-B92A09ECDE51Q39491094-ED9A9C68-69EE-487E-BB34-D8FA033640D4Q41828176-5FEDD300-328A-4D93-BA3E-F5214266DAACQ42317491-1A50D1C4-6581-4F01-8F2F-221858D3410AQ42705600-FD3BD448-7798-4C14-BAFD-C48BD6CC4B42Q46251266-09FC3D09-465A-462F-8E1C-576138DD9C51Q46770883-23E2B980-01E5-4EE7-A338-3106C8271269Q47095699-5F94BC25-BB3F-47AE-B96E-95882AB867A8Q47107372-04CE349D-E868-4CCE-9094-AC5C5A1F89EBQ47164952-1B8F239A-8DC6-4FA2-9027-4AD0127D786EQ47233994-3F2FD49D-A1CB-499E-8A7A-C8EB46744DC3Q47250551-C373E0AA-1731-4BA1-838D-9B4F71C8799A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A review of triple-negative breast cancer.
@en
A review of triple-negative breast cancer.
@nl
type
label
A review of triple-negative breast cancer.
@en
A review of triple-negative breast cancer.
@nl
prefLabel
A review of triple-negative breast cancer.
@en
A review of triple-negative breast cancer.
@nl
P2860
P1433
P1476
A review of triple-negative breast cancer.
@en
P2093
Marilyn M Bui
Roohi Ismail-Khan
P2860
P304
P356
10.1177/107327481001700305
P577
2010-07-01T00:00:00Z